Tytonis Logo
Prof. Dr. Heiko von der Leyen

Heiko von der Leyen
Managing Director, Hanover Clinical Trial Center, Hanover, Germany

Particular area of expertise: Clinical Studies, Biopharmaceuticals

Education in Pharmacology, Internal Medicine, and Cardiology at University of Hamburg, Hannover Medical School and Stanford University, CA, USA. Junior faculty member with research focus in cardiovascular gene therapy at the Division of Cardiovascular Medicine of Stanford University from 1995 to 1996. Since then external faculty member of Hannover Medical School (Professor of Internal Medicine and Experimental Cardiology).

Since 1999 several top management positions in the biotechnology industry with focus on the clinical development of advanced therapy medicinal products (tissue engineering, gene therapy, DNA medicine), 2003-2004 Chief Scientific Officer of Avontec GmbH (Munich). Since October 2005 shareholder and chief executive officer of Hannover Clinical Trial Center GmbH.